Evidence map›Paper›PMID 7935458›Full record

ArticleMolecular and cellular biology1994

The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.

K H Kalland, A M Szilvay, K A Brokstad, W Saetrevik, G Haukenes

Abstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Article
  13. Article
  14. Article
  15. Nucleolus: the fascinating nuclear body.Histochemistry and cell biology · 2008
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

K H KallandDepartment of Microbiology and Immunology, Gade Institute, Bergen High Technology Centre, University of Bergen, Norway.
A M Szilvay
K A Brokstad
W Saetrevik
G Haukenes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A retroviral regulatory protein, Rev (regulator of virion protein expression), is made in cells infected by human immunodeficiency virus (HIV). Rev is essential for the completion of the retroviral life cycle and interacts with the host cell at some posttranscriptional step in order to express the incompletely spliced HIV mRNAs from which HIV structural proteins are translated. Neither the host cell components nor the mechanisms responsible for this important regulation have been defined. We now report that Rev is a nucleocytoplasmic shuttle protein which is continuously transported between the cytoplasm, the nucleoli, and nucleoplasmic speckles enriched in RNA splicing and processing factors. The results show that Rev has the potential to interfere specifically with the splicing of the HIV pre-mRNA in the nucleoplasm and, next, guide such mRNAs to the cytoplasm for translation.

Indexed as

Amino Acid SequenceAntibodies, MonoclonalBiological Transport, ActiveCell CompartmentationCell NucleusCytoplasmDactinomycinFluorescent Antibody TechniqueGene Products, revHeLa CellsHIV-1HIV AntibodiesHumansMolecular Sequence DataPeptide Fragmentsrev Gene Products, Human Immunodeficiency VirusAntibodies, MonoclonalDactinomycinGene Products, revHIV AntibodiesPeptide Fragmentsrev Gene Products, Human Immunodeficiency Virus

Identifiers

PMID7935458
PMCPMC359279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.